US BANCORP \DE\ - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,063
+80.1%
10,2800.0%0.00%
Q2 2023$1,701
-83.0%
10,2800.0%0.00%
Q1 2023$10,033
-6.2%
10,2800.0%0.00%
Q4 2022$10,691
-10.9%
10,2800.0%0.00%
Q3 2022$12,000
-36.8%
10,2800.0%0.00%
Q2 2022$19,000
-38.7%
10,2800.0%0.00%
Q1 2022$31,000
-20.5%
10,2800.0%0.00%
Q4 2021$39,000
-26.4%
10,2800.0%0.00%
Q3 2021$53,000
+35.9%
10,2800.0%0.00%
Q2 2021$39,000
+50.0%
10,2800.0%0.00%
Q1 2021$26,0000.0%10,2800.0%0.00%
Q4 2020$26,000
+23.8%
10,2800.0%0.00%
Q3 2020$21,000
-34.4%
10,2800.0%0.00%
Q2 2020$32,000
+39.1%
10,2800.0%0.00%
Q1 2020$23,000
-37.8%
10,2800.0%0.00%
Q4 2019$37,000
+5.7%
10,2800.0%0.00%
Q3 2019$35,000
-27.1%
10,2800.0%0.00%
Q2 2019$48,000
+41.2%
10,2800.0%0.00%
Q1 2019$34,000
+25.9%
10,2800.0%0.00%
Q4 2018$27,000
-53.4%
10,2800.0%0.00%
Q3 2018$58,000
+11.5%
10,2800.0%0.00%
Q2 2018$52,000
-25.7%
10,2800.0%0.00%
Q1 2018$70,000
-10.3%
10,2800.0%0.00%
Q4 2017$78,000
+32.2%
10,2800.0%0.00%
Q3 2017$59,00010,2800.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders